Curriculum vitae cherie-Ann O. Nathan, md, facs




Дата канвертавання28.04.2016
Памер86.85 Kb.

Cherie-Ann O. Nathan, MD, FACS Curriculum Vitae

CURRICULUM VITAE


Cherie-Ann O. Nathan, MD, FACS

ADDRESS: 1501 Kings Highway

Shreveport, LA 71130-33932

Phone: W: (318) 675-6262

Fax: (318) 675-6260

Email: cnatha@lsuhsc.edu

DOB: 12/17/1963

MARITAL STATUS: Married

Husband: Dr. Raghu Nathan (pulmonary medicine & critical care)

Children: Sean (9 yrs) and Neil (7 yrs)


POSITION/TITLE:
Professor, Vice-Chairman and Director of Head & Neck Surgical Oncology and Cancer Research in the Department of Otolaryngology/Head and Neck Surgery, Louisiana State University Health Science Center and the Feist-Weiller Cancer Center Shreveport

EDUCATION:

1979-1981: Premedical; University of Bombay, Jai-Hind College H.S.C., Sciences

1981-1987: Medical School; University of Bombay, T.N.M.C., M.B.B.S. (MD)

PROFESSIONAL EXPERIENCE:

1987-1988: Residency in Otolaryngology at University of Bombay, T.N.M.C.

1988-1989: Post- Doctoral Research Fellow in Otolaryngology-Head and Neck Surgery at Johns Hopkins University School of Medicine.

1989-1990: Internship in General Surgery at Butterworth Hospital / Michigan State University.

1990-1994: Residency in Otolaryngology- Head and Neck Surgery at University of California, San Diego.

1994-1995: Clinical Instructor and Head and Neck Fellow in Div. of Otolaryngology/Head & Neck Surgery at University of California, San Diego.


EMPLOYMENT:
1994-1995: Clinical Instructor & Head and Neck Fellow in Div. of Otolaryngology/Head & Neck Surgery at University of California, San Diego.

1995-1997: Chief of ENT, VAMC Shreveport and Assistant Professor in the Dept. of Otolaryngology/ Head & Neck Surgery, LSUHSC, Shreveport.

1997-2000: Assistant Professor& Director of Head and Neck Surgical Oncology and Director of Research in the Department of Otolaryngology/HNS & the Feist-Weiller Cancer Center.

2000-2004: Associate Professor & Director of Head and Neck Surgical Oncology & Director of Research in the Department of Otolaryngology/HNS & the Feist-Weiller Cancer Center.



2004-present: Professor, Vice-Chairman & Director of Head and Neck Surgical Oncology & Director of Research in the Department of Otolaryngology/HNS & the Feist-Weiller Cancer Center.

ACADEMIC HONORS:

  1. RHODES Scholarship finalist (1987)

  2. INLAKS Scholarship for Outstanding Student-Scientist to Johns Hopkins

University School of Medicine (1988-1989)

  1. AACR Travel Award for Methods in Clinical Cancer Research (1998)

  2. AAOA Travel Award (1993)

  3. AAO-HNS Cherry Blossom Travel Award (1991)

  4. MENINO DESOUZA AWARD "The Best Student of 1986"

  5. FIRST in Surgery Practical at the University of Bombay Final MBBS

Examination (1985)

  1. T.N. MEDICAL COLLEGE AWARD "The Best Student of 1983"

  2. HONORS in Physiology at the University of Bombay (1982)

  3. DISTINCTION in the Premedical Examination (1979)

  4. C.A.B. INSTITUITION AWARD "The Best Student of 1979"

  5. CADBURY'S BEST ALL-AROUND STUDENT AWARD (1978)

  6. Nominated for “Woman Who has Made a Difference to Shreveport” (1998)

  7. Stratford’s WHO’s WHO (1999)

  8. National Registry WHO’s WHO (2000)

  9. WHO’s WHO in America Marquis Directory (2000)

  10. American Academy of Otolaryngology/HNS National Honors Award (2001)

  11. WHO’s WHO of American Women (2002)

  12. American Registry of Outstanding Professionals (2002)

  13. Guide to America’s Top Physicians (2003)

  14. WHO’s WHO in Science and Engineering (2003)

  15. International Health Profession Scientist of the year (2004)

  16. International Biographical Centre of Living Legends (2004)


ARTISTIC HONORS:


  1. Trinity College (London) Exhibition Award for Best Classical Pianist in the Asian Sub-Continent, (1977)

  2. Proficient in Classical Russian Ballet and played the lead role in "The Magic Shoes" and "The Nutcracker Suite"

  3. Honors in the Trinity College (London) Elocution Exams

  4. First place in Inter-School (1978) and Inter-collegiate Debates (1979)

  5. Sports: Inter-School Athletic Championship in 100m and 200m Sprints, (1978)

  6. Nominated by LSUHSC for “Woman who has made a difference to Shreveport”, (1988)

  7. Guest- Performance by the Nathan Family for the Sunday Afternoon Musicale Group, Shreveport, Louisiana, (2003)



GRANTS & CONTRACTS

  1. NIH/NCI grant RO1 CA 102363-01 for Multi-institutional trial: molecular analysis of margins, Principal Investigator $1,401,690 (awarded)

  2. NIH/NIDCR grant with Dr. John Sixbey RO1 DE-04-003 for Stages in Epstein-Barr Virus-Induced Tumor Progression, Co-PI $1,802,500 (pending review)

  3. NIH/NIDCR grant with Lindsey Hutt-Fletcher DE-05-001 for EBV Entry and Spread in the Oral Cavity, Co-PI $1,450,000 (pending review)

  4. NIH/NCI Grant with Dr. Raja Nassar, Mathematics and Statistics College of Engineering Louisiana Tech. University, Ruston and Grambling University (for minority students): Numerical Modeling, Analysis and Experimental Verification of the Temperature Distribution in the Region of a Tumor for Evaluating the Temperature in Hyperthermia Cancer Therapy, Co-PI $1,504, 500 (pending review)

  5. NIH/SBIR Program Project Grant National Cooperative Drug Discovery Group for Cancer RFA-CA-05-001 on Anti-Cancer Screens: Cap-Dependent Translation Inhibitors, Co-PI $5,998,225 (pending review)

  6. NIH/NCI SBIR Grant for Generation of DNA enzyme in vivo using adenoviral vector, Co-PI, $25,000 (annual total direct cost) (pending review)

  7. NIH Grant for Cancer Dual- Targeting of an Infectivity-enhanced Model, Co-PI $50,000 (pending review)

  8. NIH/NCI grant R21 CA 82618-01 for Molecular Analysis of Surgical Margins in HNSCC, Principal Investigator, $244,949 August 2000-July 2002 (awarded).

  9. Intramural Research Award 2004 for PET Imaging: Small Animal Tumor Imaging with micro-PET for Identifying Minimal Residual Disease. $12,500: 2004-2005.

  10. Edward Stiles Trust Fund at LSU-HSC Grant for mTOR Inhibitors: Adjuvant Therapy for HNSCC patients with eIF4E-positive margins, Principal Investigator, $25,000: 2003-2004.

  11. American Society for Hematology Medical Student Grant for mTOR activation in HNSCC, $2,500: 2003.

  12. Biomedical Research Foundation Grant for Radiosensitizing effects of eIF4E in HNSCC, Principal Investigator, $15,000 July 1999- June 2000.

  13. American Society of Hematology Medical Student Grant for eIF4E in Lymphomas, Advisor, $2000, summer 1999.

  14. Edward Stiles Memorial Training Grant for correlating angiogenic factors with eIF4E in HNSCC, Principal Investigator, $10,000: 1998-1999.

  15. American Academy of Otolaryngology/Head and Neck Surgery Award for A survey of the proto-oncogene eIF4E in Head and Neck Cancer, Principal Investigator, $15,000, July 1997-1998.

  16. Oral and Maxillofacial Surgery Foundation for Genetic Amplification of eIF4E in HNSCC, Co-Investigator, $50,000:1996-1997.

  17. Phase III randomized trial of concomitant radiation, cisplatin, and tirapazamine (SR259075) versus concomitant radiation and cisplatin in patients with advanced head and neck cancer (EFC4690), Co-Investigator, 2004

  18. Phase II Double-Blind, Placebo-Controlled, Randomized Study of Celcoxib (SC- 58635) in Oral Premalignant Lesions. Principal Investigator, July 2000-2004.

  19. Phase III, multi-Center, open-label, randomized study to compare the overall survival and safety of bi-weekly intratumoral administration of RPR-INGN 201 versus weekly methotrexate in 240 patients with refractory squamous cell carcinoma of the head and neck (SCCHN), Principal Investigator, 2001-2002.

  20. EPT-97-01, A Phase II Trial of Electroporation Therapy (EPT) Using the Genetronics, Inc. MedPulser System and Intratumor Bleomycin in Patient with Squamous Cell Carcinoma of the Head and Neck Who Have Failed Standard Therapy And Who Have Disease Progression Following Intratumor Bleomycin, Principal Investigator June 1998-November 1999.

  21. A248-1003-5025: A phase II multicenter, open-label study of CP-358,774 therapy in patients with advanced squamous cell cancer of the head and neck, Pfizer, Principal Investigator, 1999.

  22. A phase II Activity and safety study of intradose (cisplatin/epinephrine injectable gel) when given in combination with systemic chemotherapy paclitaxel and carboplatin in the treatment of patients with SCC if the H&N at First Relapse Co-Investigator 1999.


PUBLICATIONS: (maiden name Menezes)


  1. Book Chapters:




  1. DeSouza C, Menezes CO, Parthasarathy, R: Sleep Apnea: In Textbook of the Ear, Nose & Throat: Ed. by Chris DeSouza, Marcos Goycoolea, Carlos Ruah. Orient Longman, Chap. 5.8, p. 472-474, 1995.

  2. Stucker FJ, Nathan CO. Cutaneous Malignancy: In Head & Neck Surgery-Otolaryngology, 2nd edition. Ed. by Byron J.Bailey, Robert Kohut, Harold Pillsbury, Eugene Tardy. J.B. Lippincott Company, Chap.101, p. 1415-1438, 1999.

  3. DeSouza C., Nathan CO., Stucker FJ. Tracheostomy: In A Textbook of Pediatric Otolaryngology Head and Neck Surgery. Ed. by Chris DeSouza, James Stankiewicz, Phillip Pellitteri: Singular Publishing Co, San Diego; Chap. 8, p. 103-110, 1998.

  4. Nathan CO, Pate W, Stucker FJ. Alloplasts in Facial Reconstruction: In Surgical Reconstruction of the Face and Anterior Skull Base Ed. by Maniglia, Stucker and Stepnick: W.B. Saunders Co. Chap 25: p. 311-324, 1999.

  5. Nathan CO, De Souza C, Stucker FJ. Alloplastic Implants in Rhinoplasty: In Septorhinoplasty-Reconstructive, Functional, and Aesthetic Ed. by Maniglia.

  6. Head and Neck Surgery: Editors, DeSouza C, Gady-Har El, Nuss D, Fazekas M, Nathan C, Stucker F (in preparation)




    1. Journal Articles and Proceedings:



  1. Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J. Functional activation of overexpressed eIF4E in surgical margins of head and neck cancer patients is through activation of the Akt/mTOR pathway and has differential expression from the corresponding tumors. Clinical Cancer Research (in press 2004).

  2. Ampil F, Mills G, Heldmann M, Nathan CO. Head and Neck Cancer with Simultaneous Lung Cancer. J Louisiana SMS, 156: (in press 2004)

  3. Beal M, Chesson A, Garcia T, Stucker F, Nathan CO. Quantitative aspiration in patients with obstructive sleep apnea. Laryngoscope, 114 (6): 965-968, 2004.

  4. Sanders K, Pate W, Fowler M, Stucker F, Nathan CO. Aggressive Fibromatosis of the Parapharyngeal Space. Ear, Nose and Throat, 83 (4): 262-268, 2004.

  5. Ampil F, Nathan CO, Caldito G, Lian T, Aarstad R, Murty Krishnamsetty R. Total laryngectomy with postoperative radiotherapy: A 14-year review. American Journal of Otolaryngology, 25:88-93, 2004.

  6. Nathan CO, Amirghahari N, Rong X, Zhou H, Harrison L. EIF4E overexpression may confer radioresistance in a head and neck cancer cell line. Otolaryngology-Head and Neck Surgery, ?(?): ?, 2004.

  7. Amirghahari N, Sibley D, Rong X, Khodavandi M, Zhou H, Smith MB, Nathan CO. In vivo and in vitro effect of CCI-779 a rapamycin analogue on HNSCC. 95th Annual AACR Meeting proceedings Vol. 45, pg 850-851, 2004.

  8. Nathan CO, Amirghahari N, Abreo F, Shi R, Caldito G, Gurley M, Lusk J, Stucker F. Long Term Follow-Up of a Large Prospective Trial Indicates that Molecular Analysis of Surgical Margins with eIF4E Predicts Outcome in HNSCC patients with Node - Negative Disease. 6th International Conference on Head and Neck Cancer, 2004.

  9. Ampil F, Nathan CO. Successful chemoradiation for head and neck cancer with trismus or prevertebral fascia involvement. 6th International Conference on Head and Neck Cancer, 2004.

  10. Ampil F, Nathan CO. Surgery and postoperative radiotherapy for head and neck cancer with bone or cartilage invasion. 6th International Conference on Head and Neck Cancer, 2004.

  11. Nathan CO, Amirghahari N, Smith M, Rong X. Growth Inhibitory Effects of Rapamycin on Oral Cavity Squamous Cell Carcinoma. Otolaryngology-Head and Neck Surgery, 129(2): 216, 2003.

  12. Smith MB, Amirghahari N, Rong X, Shi R, De Bendetti A, Nathan CO. Correlation of mTOR activation in Head and Neck Cancer patients with eIF4E-positive margins. 94th Annual AACR Meeting proceedings Vol. 44, pg 678, 2003.

  13. Amirghahari N, Harrison Lynn, Rong X, Naumann I, Ampil F, Shi R, Glass J, Nathan CO. NS398 radiosensitizes a HNSCC cell line by possibly inhibiting radiation induced expression of COX-2. International Journal of Radiation Oncology, Biology, Physics, 57 (5), pg 1405-1412, 2003.

  14. Nathan CO, Amirghahari N, Rice C, Abreo F, Shi R, Stucker F. Molecular analysis of surgical margins in HNSCC patients. Laryngoscope, 112: 2129-2140, 2002.

  15. Ampil F, Nathan CO, Lian T, Stucker F, Hardin J, Aarstad R. Salvage treatment of recurrent skin cancer of the midface. Am J Clin Oncol, 25: 580-582, 2002.

  16. Ampil F, Borski G, Nathan CO, Mulcahy G, Walker M, Chin H, Stucker F. Cavernous Sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. An argument for the use of adjuvant chemotherapy. Leukemia and Lymphoma, 43(10): 2037-2040, 2002.

  17. Nathan CO, Dixie L, Stucker F. Voice-controlled robotic assist for endoscopic sinus surgery. Otolaryngology-Head and Neck Surgery, 127(2): 57, 2002.

  18. Fowler M, Nathan CO, Abreo F. Synovial Metaplasia, a specialized form of repair. A case report with literature review, Archives of Pathology and Laboratory Medicine, 126: 727-730, 2002.

  19. Ampil F, Veillon D, Nathan CO, Cotelingam J, Kottapurath K. CD23 Negative Lymphocytic Leukemia of the Tonsil: A Case Presentation. J La State Med Soc, 154:141-143, 2002.

  20. Ampil F, Caldito G, Ghali G, Nathan CO. Postoperative Radiotherapy for insecure or positive surgical margins in head and neck cancer. Oral and Maxillofacial Surgery, 425-429, 2002.

  21. Chandy B, Abreo F, Nassar R, Stucker F, Nathan CO. Expression of the proto-oncogene eIF4E in inflammation of the oral cavity. Otolaryngology Head and Neck Surgery, 126: 290-295, 2002.

  22. Goldfarb P, Biel M, Sayed-El, Hanna E, Hier M, Houck J, Klotch D, Nathan CO, Panje W, Robbins T, Shaw G, Jones V, Nasser J, Rice D, Vieira F. Treatment of recurrent Head and Neck Cancer utilizing electroporation with intralesional bleomycin: Long term survival. Proceedings of American Society of Clinical Oncology, 18: 340, 2002.

  23. Nathan CO, Amirghahari N, Rong X, Naumann I, Ampil F, Shi R, Glass J, Harrison L. Radiosensitizing and growth inhibition of a HNSCC cell line by a COX-2 inhibitor, NS398. 93rd Annual AACR meeting, Vol. 43, pg 483, 2002.

  24. Nathan CO, Leskov I, Lin M, Abreo F, Shi R, Hartman G, Glass J. COX-2 expression in dysplasia of the head and neck: correlation with eIF4E. Cancer, 92: 1888-1895, 2001.

  25. Ampil F, Nathan CO, Stucker FJ. Complicated cirrhosis of the liver in patients with head and neck cancer. Otolaryngology Head and Neck Surgery, 125: 417-419, 2001.

  26. Nathan CO, Abreo FA, Shi R, Stucker FJ. Molecular Analysis of surgical margins with the proto-oncogene eIF4E. International Journal of Molecular Medicine, 8 (1): S10, 2001.

  27. Chandy B, Todd J, Stucker FJ, Lall C, Nathan CO. Pott’s puffy tumor and epidural abscess arising from dental sepsis: a case report. Laryngoscope, 111: 1732-1734, 2001.

  28. Ampil F, Mills G, Stucker F, Burton G, Nathan CO. Radical Combined treatment of locally extensive head and neck cancer in the elderly. American Journal of Otolaryngology, 22: 65-69, 2001.

  29. Lall C, Abreo F, Agrawal G, Nathan CO. Agnogenic Myeloid Metaplasia presenting with omental implants and ascites. Applied Radiology, 131: 40-43, 2001.

  30. Yin SG, Stucker FJ, Nathan CO. Clinical Application of Botulinum Toxin in Otolaryngology, Head and Neck Practice (brief review) J Louisiana SMS, 153(2): 92-97, 2001.

  31. Sanders K, Abreo F, Rivera E, Stucker F, Nathan CO. A Diagnostic and Therapeutic Approach to Paragangliomas of the Larynx. Archives of Otolaryngology/Head & Neck Surgery, 127: 565-569, 2001.

  32. Nathan CO, Sanders K, Abreo F, Nassar R, Glass J. Correlation of p53 and the proto-oncogene eIF4E in Larynx Cancers: Prognostic Implications. Cancer Research, 60: 3599-3604, 2000.

  33. DeFatta R, Nathan CO, De Benedetti A. Reducing the level of eIF4E with antisense RNA suppresses the oncogenic properties of Head and Neck Squamous Cell Carcinoma Cell Line. Laryngoscope, 110 (6): 928-933, 2000.

  34. Meyer M, Nathan CO. Reduced F- 18 Flurodeoxyglucose uptake within marrow after external beam radiation. Clinical Nuclear Medicine, 25 (4): 279-280, 2000.

  35. Borski G, Stucker, Grafton W, Nathan CO. Leiomyoma of the Trachea: A case report and a novel surgical approach. American Journal of Otolaryngology, 21(2): 119-121, 2000.

  36. Rice C, Abreo F, Shi R, Leskov I, Stucker F, Nathan CO. Expression of Matrix Metalloproteinase-9 and eIF4E co-localize in squamous cell carcinoma of the head and neck. Otolaryngology-Head and Neck Surgery, 123 (2); 2, 2000.

  37. Nathan CO, Harris, JP, Koutnouyan, HA, and Ryan A. Absence of mRNA Encoding Estrogen Receptor in the Cochlea of the Rat: Current Awareness in Biomedicine: Steroid Receptors publication 2000.

  38. McCaffrey J, Nathan CO, Levine P, Burkey B, Reiber M, Parke R, Hart J, Urken M, Stack B, Parey S, Shyr Y, Tarr C, Stawiasz, Lore J, Goldstein J, Sisson G, Day T. Head and Neck Cancer Screening: a multi-institutional effort. 5th International Conference on Head and Neck Cancer, 30: 49, 2000.

  39. Nathan CO, Harris, JP, Koutnouyan, HA, and Ryan A. Absence of mRNA Encoding Estrogen Receptor in the Cochlea of the Rat. Acta Otolaryngologica, 119: 853-857, 1999.

  40. Franklin S, Pho T, Abreo F, Nassar R, De Benedetti A, Stucker F, Nathan CO. Immunohistochemical Detection of the Proto-Oncogene eIF4E in Larynx and Hypopharynx Cancers. Archives of Otolaryngology/Head & Neck Surgery, 125:177-182, 1999.

  41. Nathan CO, Yin S, Stucker FJ. Botulinum Toxin: Adjunctive Treatment for Posterior Glottic Synechiae. Laryngoscope, 109 (8): 855-857, 1999.

  42. Nathan CO, Franklin S, Abreo F, Nassar R, De Benedetti A, Glass J. Analysis of Surgical Margins with the Molecular Marker eIF4E: a prognostic factor in patients with Head & Neck Cancer. J Clin Oncol, 17 (9): 2909-2914, 1999.

  43. Nathan CO, Franklin S, Abreo F, Nassar R, De Benedetti A, Williams J, Stucker F. Expression of eIF4E during head & neck tumorigenesis: possible role in angiogenesis. Laryngoscope, 109 (8); 1253-1258; 1999.

  44. Sorrells D, Ghali G, De Benedetti A, Nathan CO, Li BD. Progressive Amplification and Overexpression of the Eukaryotic Initiation Factor 4E Gene in Different Zones of Head and Neck Cancers. J Oral Maxillofac Surg, 57(3):294-299, 1999.

  45. Sorrells D, Ghali G, Meschonat C, DeFatta R, Black D, Liu L, De Benedetti A, Nathan CO, Li BD. Competitive PCR to Detect eIF4E Gene Amplification in Head and Neck Cancer. Head & Neck, 21: 60-65, 1999.

  46. Franklin S, Pho T, Abreo F, Nassar R, De Benedetti A, Stucker F, Nathan CO. Immunohistochemical Detection of the Proto-Oncogene eIF4E in Larynx and Hypopharynx Cancers: selected for the Journal Club of Clinical Oncology, No. 11, 1999.

  47. Ampil FL, Mills GM, Nathan CO, Stucker FJ, Chin HW. Radical Combined treatment for locally extensive head and neck cancer in the elderly. 90th Annual AACR meeting, 40: pg 642, 1999.

  48. Goldfarb P, Biel M, Hanna E, Houck J, Klotch D, Nathan CO, Panje W, Robbins T, Shaw G, El-Sayed S, Hier M, Jones V, Nasser J, Rice D. A Phase II Study using electroporation and intratumoral bleomycin in patients with recurrent head and neck cancer. A safe and active treatment approach. Proceedings of American Society for Clinical Oncology, 18: 59, 1999.

  49. Ampil FL, Ghali GE, Nathan CO, Hardin JC. Effects of postoperative external beam irradiation after carotid artery stripping of nodal metastasis. J. Oral Maxillofacial Surgery, 56: 845-848, 1998.

  50. Ampil F, Ghali G, Hardin J, Hoasjoe D, Aarstad R, Nathan CO, Stucker FJ. Post-operative radiotherapy for nodal metastasis involving the carotid artery. The Oral Oncology, Vol. “V”: 239-341, 1998.

  51. Nathan CO, Franklin S, Abreo F, Nassar R. Immunohistochemical detection of the proto-oncogene eIF4E in surgical margins of Head and Neck Cancer patients may predict recurrence. Cancer Detection and Prevention, 22(1), 1998.

  52. Nathan CO, Franklin S, Abreo F, Stucker F. A Molecular Analysis of Surgical Margins using eIF4E in Head and Neck Squamous cell cancers. Otolaryngology-Head and Neck Surgery, 119: 84, 1998.

  53. Haydon M, Googe J, Meschonat C, Gautreaux M, Williams J, De Benedetti A, Eggerstedt J, Nathan CO, Li B: The Detection of the eukaryotic initiation factor 4E (eIF4E) in Solid Tumors. Proc. Assoc. Academic Surgery, 32: 167, 1998.

  54. Nathan CO, Liu L, Li B, Abreo F, Nandy I, De Benedetti A. Detection of the proto-oncogene eIF-4E in surgical margins may predict recurrence in head and neck cancer. Oncogene, 15: 579-584, 1997.

  55. Nathan CO, Carter P, Liu L, Li B, Abreo F, Tudor A, Zimmer S, De Benedetti A. Elevated expression of eIF-4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene, 15: 1087-1095, 1997.

  56. Nathan CO, Seid AB. Neonatal rhinitis - A new approach to a seasonal disease. International Journal of Pediatric Otorhinolaryngology, 39: 59-65, 1997.

  57. Ampil FL, Menezes CO. Glottic Cancer with subglottic extension. Radiation Medicine, 15:103-10724, 1997.

  58. Nathan CO, Liu L., De Benedetti A. The role of eIF4E in neovascularization of head and neck cancers. Otolaryngology/Head and Neck Surgery, 117: 133 1997.

  59. Sorrells DL, Meschonat C, De Benedetti A, Nathan CO, Ghali G, Li BD. Gene Amplification and protein elevation of eIF4E in Head and Neck Squamous Cell Carcinoma. J. Oral Maxillofacial Surgery, 55(8) Supp. 3: 65-66, 1997.

  60. Ampil FL, Ghali GE, Hardin JC, Hoasjoe D, Aarstad R, Nathan CO, Stucker FJ. Postoperative radiotherapy for head and neck cancer involving carotid artery. Proceedings of the 5th International Congress on Oral Cancer, 34: 97, 1997.

  61. Sorrells D., Ghali G, Nathan CO, De Benedetti A., Meschonat C., DeFatta R., Li, B.D. Detection of eIF4E Gene Amplification in Head and Neck Neoplasms. Proceedings of the Society of Head and Neck Surgeons, 43: 117-118, 1997.

  62. Sorrells, D, De Benedetti A, Nathan CO, Ghali G, Li B: eIF4E and malignant transformation. Proceedings of the Assoc. Academic Surg. 31:173, 1997.

  63. Menezes CO, De Benedetti A, Abreo, F. A survey of the proto-oncogene/translation initiation factor eIF-4E in head and neck squamous cell cancers: Otolaryngology-Head and Neck Surgery, 115:72, 1996.

  64. Ampil FL, Hoasjoe DK, Aarstad RF, Menezes CO, Nickleson RA, Stucker FJ. Supraglottic Laryngeal or Base of tongue cancer involving vallecula. Louisiana State Medical Society, 148: 435-439, 1996.

  65. Menezes CO, Harris JP, Koutnouyan HA., and Ryan A. Absence of mRNA Encoding Estrogen Receptor in the Cochlea of the Rat. Otolaryngology- Head and Neck Surgery, 113: 143, 1995.

  66. Menezes CO, Davidson T. Endoscopic resection of Sphenoid Sinus Osteoma: A Case Report. Ear Nose Throat, 73(8): 598-600, 1994.

  67. Menezes CO, Murry T, Woodson G.: Arytenoid Adduction and Cricopharyngeal Myotomy for Management of Vagal Paralysis. Otolaryngology- Head and Neck Surgery, 107 (2): 219, 1992.

  68. Richtsmeier, W.J., Menezes, C. Direct effects of TNF and the interferons on carcinomas of the head and neck Immunobiology in Otology, Rhinology and Laryngology, Proceedings of the Third International Academic Conference on Immunobiology in Otology, Rhinology and Laryngology; Harris JP, Lim DJ, McCabe BF, Mogi G and Veldman JE(ed), Kugler Publications BV, Amsterdam, 1992.

  69. Menezes CO, Kearns DB, Mair E. Newborn airway obstruction resulting from bilateral congenital nasolacrimal duct cysts. Otolaryngology Head and Neck Surgery, 107 (2): 305, 1992.

  70. Menezes CO, Richtsmeier, W. Properties of a Parotid Derived Mucoepidermoid Carcinoma in Tissue Culture. Otolaryngology- Head and Neck Surgery, 103 (2); 226, 1990.

  71. Menezes CO, Richtsmeier W.J. IFN-gamma Sensitive Head and Neck Derived Squamous Cell Cultures are Insensitive to TNF- alpha. Otolaryngology- Head and Neck Surgery, 101(2): 191, 1989.

  72. Richtsmeier W.J., Menezes CO, Ravenhill G.O., Koch W.M.: Cytolysis in Head and Neck Squamous Cell Carcinoma Inducted by IFN- gamma. Otolaryngology- Head and Neck Surgery, 101 (2): 166, 1989.

  73. Menezes CO, Ryan A: Expression of Five Subunit Isoforms of Na-K-ATPase in the Developmental Rat Cochlea. Otolaryngology- Head and Neck Surgery, 105(2): 191, 1991.

  74. DeSouza C, Menezes CO, DeSouza R, Ogale S, Morris M, Desai A: Profile of Congenital cholesteatomas of the petrous apex. Post-graduate Journal of Medicine, 35(2): 93-97, 1989.

  75. DeSouza C, DeSouza R, Menezes CO, Heiming R, Rosenbaum T, DeSouza S: Mucoceles, Proptosis and Transorbital Frontoethmoidectomy. Orbit, 7(3): 167-173, 1988.

  76. Practical Reviews in Otolaryngology: Selection of the article Nathan CO, Franklin S, Abreo F, Nassar R, De Benedetti A, Glass J. Analysis of Surgical Margins with the Molecular Marker eIF4E: a prognostic factor in patients with Head & Neck Cancer. J Clin Oncol, 17 (9): 2909-2914, 1999.

  77. Journal of The American College of Surgeons Vol. 197 (1): 2003: What’s New in Otolaryngology. Molecular Biology Diagnostics quotes the work on eIF4E in Head and Neck Cancer.


Submitted for publication:


  1. Lee M, Nathan CO: False positive PET scan findings in Vocal Cord Paralysis.

  2. Moody, CA, Scott RS, Amirghahari N, Nathan CO, Young LS, Dawson CW, Sixbey JW. Epstein-Barr Virus-Encoded LMP2A signals through the cell growth regulator mTOR to enhance tumor progression.

  3. Reddy M, Nathan CO, Ramaswamy M. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Sebaceous Carcinoma of the Eyelid.

  4. Kumar V, Blachon B, Gu Xin, Scarborough Nathan CO, Subashini Y. Anaplastic Thyroid cancer and Hyperthyroidism: Case Report

  5. Pham J, Yin S, Morgan M, Stucker F, Nathan CO. Botulinum Toxin: A Helpful Adjunct to early resolution of Laryngeal granulomas.

  6. Ampil FL, Mills GM, Caldito G, Burton G, Nathan CO, Aarstad R, Lian T, Stucker FJ, Hardin J. Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome.

  7. Ampil F, Mills G, Nathan CO, Burton G, Mansour. Positive response of advanced oropharyngeal cancer and trismus to chemoradiation.

  8. Price K, Fowler M, Grafton W, Stucker F, Nathan CO. Atypical Fibroxanthoma of the Skin.




    1. Abstracts Presented at Meetings




  1. Radioresistance for Academy NY Sept 2004

  2. Ampil F, Caldito G, Hardin J, Krishnamsetty R, Nathan CO. Surgery and post-operative radiotherapy for head and neck cancer with bone or cartilage invasion. 6th International Head and Neck Conference, Washington DC, August, 7-11th, 2004.

  3. Ampil F, Caldito G, Hardin J, Krishnamsetty R, Nathan CO. Successful chemoradiation for head and neck cancer with trismus or prevertebral fascia involvement. 6th International Head and Neck Conference, Washington DC, August, 7-11th, 2004.

  4. Lee M, Nathan CO: False positive PET scan findings in Vocal Cord Paralysis, Southern Section, Triologic, 2004.

  5. Thibodeaux J, Nathan CO. Bilateral Vocal Cord Paralysis in Parkinson’s patients, Southern Section, Triologic, 2004.

  6. Nathan CO, Amirghahari N, Abreo F, Shi R, Caldito G, Gurley M, Lusk J, Stucker F. Long Term Follow-Up of a Large Prospective Trial Indicates that Molecular Analysis of Surgical Margins with eIF4E Predicts Outcome in HNSCC patients with Node - Negative Disease. 6th International Conference on Head and Neck Cancer, Washington DC, August, 7-11th, 2004.

  7. Amirghahari N, Sibley D, Rong X, Khodavandi M, Zhou H, Smith MB, Nathan CO. In vivo and in vitro effect of CCI-779 a rapamycin analogue on HNSCC. 95th Annual AACR Meeting, Orlando, Florida, proceedings 2004 (accepted for poster presentation, March 30th, 2004).

  8. Moody CA, Amirghahari N, Scott RS, Nathan CO, Sixbey JW. The effect of LMP2A expression on the mTOR pathway: A potential mechanism by which EBV promotes tumor progression. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, proceeding, pg 43, 2004.

  9. Donnellan K, Jones LM, Amirghahari N, Abreo F, Caldito G, Nathan CO: Correlation of Phospho-mTOR (Ser2448) and AKT with the proto-oncogene eIF4E in HNSCC patients. Louisiana Chapter American College of Surgeons, New Orleans, Louisiana, 2004.

  10. Donnellan K, Nathan CO, Jones ML, Amirghahari N, Abreo F, Caldito G, Zhou H: Correlation of Phospho-mTOR (Ser2448) with the proto-oncogene eIF4E in HNSCC patients. American Federation for Medical Research, Southern Regional Meeting, New Orleans, Louisiana, 2004.

  11. Nathan CO, Amirghahari N, Sibley D: Phospho-mTOR activation in HNSCC maybe induced by Akt. 107th Annual Meeting at COSM, Phoenix, Arizona, 2004.

  12. Amirghahari N, Smith M, Rong X, Shi R, De Benedetti A, Nathan CO: Correlation of mTOR activation in head and neck cancer patients with eIF4E positive margins. 94th Annual Meeting AACR, Washington, DC, 2003.

  13. Smith M, Amirghahari N, Rong X, Nathan CO: Anti-tumor effects of rapamycin in head and neck cancer, The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, proceeding pg, 12, 2003.

  14. Naumann I, Amirghahari N, Rong X, Shi R, Nathan CO: COX-2 inhibitors and effects on COX-2 protein after radiation. VII, Symposium on Head and Neck Cancer in Düsseldorf, 2003.

  15. Nathan CO, Amirghahari N, Smith M, Rong X: Growth inhibitory effects of rapamycin on oral cavity squamous cell carcinoma. Otolaryngology-Head and Neck Surgery, Orlando, Florida, 2003.

  16. Amirghahari N, Smith M, Rong X, Abreo F, Jones LM, Shi R, Nathan CO: mTOR activation in head and neck cancer. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2003.

  17. Smith M, Amirghahari N, Rong X, Nathan CO: Anti-tumor effects of rapamycin in head and neck cancer, The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2003.

  18. Pham J, Yin S, Morgan M, Stucker F, Nathan CO: Vocal-fold granulomas: botulinum toxin maybe first line of treatment. Southern Section Meeting, Naples, Florida, 2003.

  19. Rice C, Stucker F, Nathan CO: Endoscopic management of complex frontal sinus mucosal: A safe approach with image guidance. Southern Section Meeting, Naples, Florida, 2003.

  20. Nathan CO, Department of Otolaryngology/HNS: Chemoprevention in Head and Neck Cancer, Shreveport, Louisiana, March 2003.

  21. Nathan CO, Department of Hematology/Oncology: mTOR inhibitors as adjuvant therapy for head and neck cancer patients, Shreveport, Louisiana, June 2003.

  22. Nathan CO, Department of Otolaryngology/HNS: Adjuvant Therapy for Minimal Residual Disease, Shreveport, Louisiana, October 2003.

  23. Stucker F, Nathan CO, Lian T: Management experience in 142 cases of rhinophyma. IFOS World Congress, Cairo Egypt, 2002.

  24. Stucker F, Nathan CO, Lian T: The use of autogenous cartilage grafts in revision nasal surgery. IFOS World Congress, Cairo Egypt, 2002.

  25. Nathan CO, Dixie L, Stucker F: Voice-controlled robotic assist for endoscopic sinus surgery. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting, San Diego, California, 2002.

  26. Amirghahari N, Smith M, Rong X, Glass J, Stucker F, Nathan CO: Upregulation of COX-2 protein induced by radiation is inhibited by COX-2 inhibitor NS398 and appears to be post-transcriptional. Sixth Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, McLean, Virginia, 2002.

  27. Beal M, Chesson A, Garcia T, Stucker F, Nathan CO: Quantitative aspiration during sleep in patients suspected of suffering from obstructive sleep apnea. Eastern Section of the American Laryngological, Rhinological and Otological Society, Inc., Philadelphia, PA, 2002.

  28. Amirghahari N, Rong X, Naumann I, Ampil F, Shi R, Glass J, Harrison L, Nathan CO: Radiosensitizing and growth inhibition of a HNSCC cell line by a COX-2 inhibitor, NS398. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2002.

  29. Goldfarb P, Biel M, Sayed-El, Hanna E, Hier M, Houck J, Klotch D, Nathan CO, Panje W, Robbins T, Shaw G, Jones V, Nassar J, Rice D, Vieira F: Treatment of recurrent head and neck cancer utilizing electroporation with intralesional bleomycin: Long term survival. 39th ASCO Annual Meeting, Chicago, Illinois, 2002.

  30. Nathan CO, Amirghahari N, Rong X, Naumann I, Ampil F, Shi R, Glass J, Harrison L: Radiosensitizing and growth inhibition of a HNSCC cell line by a COX-2 inhibitor, NS398. 93rd Annual AACR Meeting, San Francisco, California, 2002.

  31. Nathan CO, Department of FamilyMedicine: Management of the thyroid nodule; Shreveport, Louisiana, January 4th, 2002.

  32. Nathan CO, Department of Otolaryngology/HNS: Management of thyroid diseases; Shreveport, Louisiana, March 11th, 2002.

  33. Karen M, Nathan CO, Stucker F: Use of perichondrial cutaneous grafts in head and neck reconstruction. Combined Otolaryngology Spring Meeting; Palm Springs California, 2001.

  34. Ampil FL, Nathan CO, Stucker F: Use of Perichondrial cutaneous grafts in head and neck reconstruction. Combined Otolaryngology Spring Meeting, Palm Springs California, 2001.

  35. Ampil FL, Nathan CO, Mulcahy G, Caldito G, Stucker F, Aarstad RF, Lian TS: Is total laryngectomy alone enough in patients with T3N0M0 glottic cancer? Review of a 17-year experience, Southern Medical Society, New Orleans, 2001.

  36. Ampil FL, Mills G, Burton G, Caldito G, Nathan CO, Stucker F, Aarstad RF, Lian TS, Hardon JC: Chemoradiation-induced regression of advanced cervical lymphadeopathy in head and neck cancer as a predictor of outcome. 8th Hong Kong International Cancer Congress 6th Research postgraduate symposium, HKU, 2001.

  37. Lian TS, Karen M, Nathan CO, Stucker F: Use of perichondral cutaneous grafts in eyelid reconstruction of children. American Society of Pediatric Otolaryngology (ASPO), Scottsdale, Arizona, 2001.

  38. Chandy B, Todd J, Stucker F, Lal C, Nathan CO: Pott’s puffy tumor and epidural abscess arising from dental sepsis: a case report. Southern Section Triologic Meeting, Marco Island, Florida, 2001.

  39. Burton G, Ampil FL, Mills G, Nathan CO, Gamage C: Nasopharyngeal cancer: multidisciplinary therapy with cisplatin, 5-fluorouracil, etopside and radiotherapy. 10th International Congress on Anticancer Treatment, Paris, France, 2000.

  40. McCaffrey J, Nathan CO, Levine P, Burkey B, Reiber M, Parke R, Hart J, Urken M, Stack B, Parey S, Shyr Y, Tarr C, Stawiasz, Lore J, Goldstein J, Sisson G, Day T: Head and neck cancer screening: a multi-institutional effort. 5th International Conference on Head and Neck Cancer, San Francisco, California, 2000.

  41. Ampil FL, Mills G, Caldito G, Nathan CO, Stucker F: Induction chemotherapy followed by concomitant chemoradiation for cervical lymphadenopathy. 2nd International Chicago Symposium on Malignancies of the Chest and Head and Neck, Chicago, Illinois, 2000.

  42. DeFatta R, Nathan CO, De Benedetti A: Reducing the level of eIF4E with antisense RNA suppresses the oncogenic properties of head and neck squamous cell carcinoma cell line. Combined Otolaryngology Spring Meetings, Orlando, Florida, 2000.

  43. Nathan CO, Leskov I, Abreo F, Shi R, Stucker F: Correlating the expression of eIF4E and COX-2 in head and neck tumorigenesis. 5th International Conference on Head and Neck Cancer, San Francisco, California, 2000.

  44. Yin SP, Pate W, Nathan CO, Driscoll P, Watkings W, Batchelor B, Stucker F: Diagnosis and treatment of immobile vocal fold after thyroid tumor surgery: laryngeal joint origin. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2000.

  45. Nathan CO, Leskov I, Abreo F, Shi R, Stucker F: Correlating the expression of eIF4E and COX-2 in head and neck tumorigenesis. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2000.

  46. Rice C, Abreo F, Shi R, Leskov I, Stucker F, Nathan CO: A strong correlation exists between matrix metalloproteinase-9 and eIF4E in squamous cell carcinoma of the head and neck. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 2000.

  47. Rice C, Abreo F, Shi R, Leskov I, Stucker F, Nathan CO: Expression of matrix metalloproteinase-9 and eIF4E co-localize in squamous cell carcinoma of the head and neck. American Academy of Otolaryngology/HNS, Washington, DC, 2000.

  48. Price K, Sanusi I, Stucker F, Nathan CO: Metastatic malignant fibrohistiocytoma of the parotid: a case report. Southern Medical Society, 2000 (3rd Place Resident Award).

  49. Sanders K, Abreo F, Rivera E, Stucker F, Nathan CO: A diagnostic and therapeutic approach to paragangliomas of the larynx. Western Section Triologic Meeting, San Francisco, California, 2000.

  50. Borski G, Aarstad R, Stucker F, Nathan CO: Plasma cell neoplasms of the sphenoid sinus: a diagnostic and treatment dilemma. Western Section Triologic Meeting, San Francisco, California, 2000.

  51. Chandy B, Abreo F, Nassar R, Stucker F, Nathan CO: Expression of the proto-oncogene eIF4E in dysplasia: a potential biomarker. Southern Section Triologic Meeting, Petersburg, Florida, 2000.

  52. Sanders K, Franklin S, Abreo F, Nassar R, Stucker F, Nathan CO: Correlation of p53 and the proto-oncogene eIF4E in larynx cancers. 85th Clinical Congress of the American College of Surgeons, San Francisco, California, 1999.

  53. Ampil FL, Mills G, Nathan CO, Stucker F, Chin HW: Radical combined treatment for locally extensive head and neck cancer in the elderly: 90th Annual Meeting AACR, Philadelphia, PA, 1999.

  54. Goldfarb P, Biel M, Hanna E, Houck J, Klotch D, Nathan CO, Panje W, Robbins T, Shaw G, El-Sayed S, Hier M, Jones V, Nassar J, Rice D: A phase II study using electroporation and intratumoral bleomycin in patients with recurrent head and neck cancer. A safe and active treatment approach. 35th Annual Meeting ASCO, Atlanta, Georgia, 1999.

  55. Franklin S, Abreo F, Nassar R, De Benedetti A, Williams J, Stucker F, Nathan CO: Expression of eIF4E during head and neck Tumorigenesis: possible role in angiogenesis. Triological Society Southern Section Meeting, New Orleans, Louisiana, 1999. (Award for Best Paper).

  56. Nathan CO, Yin S, Stucker F: Botulinum Toxin: Adjunctive treatment for posterior glottic synechiae. Triological Society Southern Section Meeting, New Orleans, Louisiana, 1999.

  57. Borski G, Stucker F, Nathan CO: Leiomyoma of the trachea: A new approach. Triological Society Southern Section Meeting, New Orleans, Louisiana, 1999.

  58. Sanders K, Pate W, Fowler M, Stucker F, Nathan CO: Aggressive fibromatosis of the parapharyngeal space. Southern Medical Society Annual Meeting, Dallas, Texas, 1998. (3rd Place Award).

  59. DeFatta R, Gan W, De Benedetti A, Rhoads R, Franklin S, Abreo F, Stucker F, Nathan CO: Using the eukaryotic translation initiation factor eIF4G as a diagnostic and prognostic tool to identify HNSCC. Southern Medical Society Annual Meeting, 1998. (2nd Place Award).

  60. Nathan CO, Franklin S, Abreo F, Nassar R: Immunohistochemical detection of the proto-oncogene eIF4E in surgical margins of head and neck cancer patients may predict recurrence. 4th International Symposium of Predictive Oncology and Therapy, Nice France, 1998.

  61. Nathan CO, Frankslin S, Abreo F, Stucker F: A molecular analysis of surgical margins using eIF4E in head and neck squamous cell cancers. American Academy of Otolaryngology-Head and Neck Surgery, Oakland, California.

  62. Gan W, DeFatta R, De Benedetti A, Nathan CO, Rhodas R: The eukaryotic translation initiation factors eIF4G and eIF4E are coregulated in tumor cell lines and cell over – or underexpressing eIF4E. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 1998.

  63. Franklin S, Pho T, Abreo F, Nasser R, De Benedetti A, Stucker F, Nathan CO: Immunohistochemical detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 1998.

  64. DeFatta R, De Benedetti A, Nathan CO, Li B, Williams, BJ: The role of eIF-4E in vascularization and progression of breast cancer. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 1998.

  65. Nathan CO, Liu L, De Benedetti A: The role of eIF4E in neovascularization of head and neck cancers. American Academy of Otolaryngology/Head and Neck Surgery, San Francisco, California, proceeding: OTO/HNS 117, 1997.

  66. Sorrells DL, Meschonat C, De Benedetti A, Nathan CO, Ghali G, Li BD: Gene amplification and protein elevation of eIF4E in head and neck squamous cell carcinoma. American Academy of Oral Maxillofacial Surgery, 1997.

  67. Ampil FL, Ghali G, Hardin JC, Hoasjoe D, Aarstad RF, Nathan CO, Stucker F: Postoperative radiotherapy for head and neck cancer involving carotid artery. 5th International Congress on Oral Cancer, London, UK, 1997.

  68. Sorrells DL, Ghali G, Nathan CO, De Bendetti Al, Meschonat C, DeFatta R, Li BD: Detection of eIF4E gene amplification in head and neck neoplasms. Proceedings of the American Society of Head and Neck Surgeons, Toronto, Canada, 1997.

  69. Nathan CO, Li L, Li B, Abreo F, De Benedetti A: Detection of the eIF4E oncoprotein at the surgical margins of squamous cell cancers of head and neck. The Ray A. Barlow Scientific Symposium, Shreveport, Louisiana, 1997.

  70. Sorrells DL, Ghali GE, Meschonat CJ, DeFatta R, Nathan CO, De Benedetti A, Li B: Detection of eIF4E gene amplification in head and neck neoplasms. The Ray A. Barlow Scientific Symposium, proceeding, Shreveport, Louisiana, 1997.

  71. Menezes CO, De Benedetti A, Abreo F: A survey of the proto-oncogene eIF4E in head and neck squamous cell cancers. American Academy of Otolaryngology/Head and Neck Surgery, Washington, DC, 1996.

  72. Menezes CO, Seid AB: Neonatal rhinitis – A new approach to a seasonal disease. American Society of Pediatric Otolangology, Durango, Colorado, 1995.

  73. Menezes CO, Harris JP, Koutnouyan HA, Ryan A: Absence of mRNA encoding estrogen receptor in the cochlea of the rat. American Academy of Otolaryngology/Head and Neck Surgery, New Orleans, Louisiana, 1995.

  74. Harris JP, Kuppersmith RB, Menezes CO: Exogenous reproductive hormone as a etiology of meniere’s syndrome. American Neurotology Society Annual Spring Meeting, Scottsdale, Arizona, 1993.

  75. Menezes CO, Ryan A: Expression of five subunit isoforms of Na-K-ATPase in the development rat cochlea. American academy of Otolaryngology/Head and Neck Surgery, Washington, DC, 1992.

  76. Menezes CO, Murry T, Woodson GE: Arytenoid adduction and cricopharyngeal myotomy for management of vagal paralysis. American Academy of Otolaryngology/Head and Neck Surgery, Washington, DC, 1992.

  77. Menezes CO, Mail E, Kearns DB, Pransky S, Seid AB: Development of a new stent for choanal atresia. American Society for pediatric Otolaryngology, Palm Spring, California, 1992.

  78. Richtsmeier WJ, Menezes CO, Harris JP, Lim DJ, McCabe BF, Mogi G, Veldman JE: Direct effects of TNS and the interferons on carcinomas of the head and neck immunobiology in otology, rhinology and larngology, proceedings of the 3rd International Academic Conference on Immunobioogy in Otology, Rhinology and Larngology, Kugler Publications BV, Amsterdam, 1992.

  79. Menezes CO, Kearns DB, Mair E: A case report on bilateral congenital nasolacrimal duct cyst obstruction. American Academy of Otolaryngology Head and Neck surgery, Washington, DC, 1992.

  80. Menezes CO, Richtsmeier WJ: IFN-gamma sensitive head and neck derived squamous cell cultures are insensitive to TNF-alpha. Academy of Otolaryngology/Head and Neck Surgery Research Forum, New Orleans, Louisiana, 1989.

  81. Richtsmeier WJ, Menezes CO, Ravenhill GO, Koch WM: Cytolysis in head and neck squamous cell carcinoma inducted by IFN-gamma. American Academy of Otolaryngology/Head and Neck Surgery Research Forum, New Orleans, Louisiana, 1989.

  82. Menezes CO, Richtsmeier WJ: Properties of a parotid derived mucoepidermoid carcinoma in tissue culture. American Academy of Otolaryngology/Head and Neck Surgery, Washington, DC, 1988.


INVITED LECTURESHIPS


  1. University of California San Diego 25th Anniversary Academic Conference, June1996.

  2. Third Annual Innovations in Otolaryngology, Sun Valley: PET Scans in Head and Neck Cancer, February 1996.

  3. Invited Key Note Speaker for Ray A. Barlow Scientific Symposium, January 1997.

  4. Panel on Current Management of N0 Necks in advanced disease, Sixth Annual Innovations in Otolaryngology, February 1999.

  5. Panel on Mid-Face Fractures, Sixth Annual Innovations in Otolaryngology, February 1999.

  6. Lung Cancer Interest Group Speaker, City-Wide Pulmonary Group, February 1999.

  7. Invited Speaker, University of Iowa Grand Rounds, June1999.

  8. Invited Speaker, M.D. Anderson Grand Rounds, July 1999.

  9. Tata Memorial Cancer Hospital Grand Rounds, India 1999.

  10. Moderator for the American Academy of Otolaryngology National Meeting 2000.

  11. Consultant’s Advisory Panel for Sinusitis: March 2-4, New Orleans 2000.

  12. Seventh Annual Innovations in Otolaryngology, February 2000.

  13. Program Committee for the Southern Section of the Triologic, 2000.

  14. Med Lecture.com: Botulinum Toxin: An adjunct to treatment of posterior glottic stenosis, February, 2001.

  15. Grand Rounds at AHEC Arkansas Cancer Conference March 31st, 2001.

  16. 6th World Congress on Advances in Oncology & 4th International Symposium on Molecular Medicine; October 18-20, 2001.

  17. Grand Rounds Wyoming Medical Center: The role of COX-2 inhibitors in head and Cancer; September 4, 2001.

  18. City-Wide Lung Interest Group May 2001: Molecular Therapy of Lung Cancer.

  19. Invited Speaker Cancer Symposium: June 2001 Chemoprevention in HNSCC.

  20. Inducted into the Triologic Society 2001

  21. Dental Hygiene Society speaker: April 16, 2002.

  22. Family Medicine Grand Rounds: Management of the thyroid nodule; January 4, 2002.

  23. Willis-Knighton Cancer Center Grand Rounds: Head and neck cancer and the current trials; February 21, 2002.

  24. Invited Speaker Dept. of Otolaryngology Vanderbilt Sept. 2002: eIF4E, a novel molecular marker in HNSCC has promising clinical implications.

  25. North West Louisiana School of Nursing Symposium: Treatment of Head and Neck Cancer 2002.

  26. 10th Annual Innovations in Otolaryngology 2003 Panel Moderator for Sinus Surgery.

  27. 10th Annual Innovations in Otolaryngology 2003: Overview of Robotics in Otolaryngology.

  28. 10th Annual Innovations in Otolaryngology 2003: Chemoprevention of Head and Neck Cancer.

  29. Louisiana Gene Therapy Consortium: Gene Therapy in Head and Neck Cancer, March 2003.

  30. Hematology/Oncology Grand Rounds: mTOR inhibitors as adjuvant therapy for head and neck cancer patients, June, 2003.

  31. Wyeth-Ayerst Oncology Study Group with CTEP division of NCI: CCI-779 in HNSCC August 5th, 2003.

  32. Northwestern State University Oncology Workshop: What’s new in Head and Neck Cancer August, 2003.

  33. Key Note Speaker for the International AAOI: February, 2004.

  34. Southwest Oncology Group Head and Neck Committee Invited Speaker: Establishing a Multi-institutional Trial for Molecular Analysis of Surgical Margins. October 2, 2003.

  35. Women by the YMCA, November 2003.

  36. Invited to set up the web page for Head and Neck Cancer Patients, 2003.

  37. Invited Speaker for Molly web speech therapy students lecture on voice disorders 2004.

  38. Invited Speaker for 13th Annual Carroll W. Feist Weiller Symposium, 2004.

  39. Voice and swallowing rehabilitation of head and neck cancer patients, Feist Weiller Symposium, 2004.

  40. AHEC: on voice disorder October, 2004.

  41. KTBS: Channel 3, ABC head and neck screening 2004.

  42. MS I voice disorders 2004.

  43. Ray Barlow Symposium: mTOR inhibitors as adjuvant therapy for head and neck cancer patients, 2004.

  44. Invited Speaker for UT Houston, April, 2004.

  45. Invited Speaker for UT Galveston, April, 2004.

  46. Invited Speaker University of Milwaukee, July 2004.


CONTRIBUTIONS TO JURIED OR REFEREED PUBLICATIONS


  1. Reviewer for “Archives of Otolaryngology/Head & Neck Surgery 1998

  2. Ad Hoc Reviewer for National Cancer Institute (NCI), RAID Review 1999

  3. Reviewer for Head and Neck 2000

  4. Consultant’s Advisory Panel for Sinusitis: March 2-4, New Orleans 2000

  5. Referee for Expert Review of Anticancer Therapy 2001

  6. Guest Expert for the Laryngoscope Interactive 2001

  7. Editorial Review Panel: Otolaryngology/Head and Neck Surgery 2002

  8. Reviewer Clinical Cancer Research 2002

  9. Ad Hoc Reviewer: American Journal of Pathology 2003

  10. Ad Hoc Reviewer: Cancer Detection and Prevention 2003

  11. Reviewer for Laryngoscope 2000- present

  12. Academy Grant Review 2004

  13. SUO’s Resident Education Committee 2004

  14. North American Skull Base Society 2004

  15. Member of American Federation for Medical Research 2004

  16. Academy of OTO/HNS grant review 2004


NATIONAL COMMITTEES


  1. National Committee of American College of Surgeons for Biomarkers in Head

  2. and Neck Cancer 1999

  3. Young Academicians Committee for the National SUO 1998-Present

  4. Program Committee for the Southern Section of the National

  5. Education Committee for AAOI 2001-Present

  6. American Head and Neck Society: Education Committee 2001-Present

  7. Delegate to the Louisiana State Medical Society 2001

  8. Southwest Oncology Group/Head and Neck Committee 2003-Present

  9. American Head and Neck Society: Research Committee 2003-Present

  10. Society of University Otolaryngologist: Resident Education Hours 2004



TEACHING ACTIVITIES


  1. Head and Neck Cancer Weekly Tumor Board

  2. Otolaryngology Grand Rounds Discussion Group

  3. Otolaryngology Resident and Student Didactic Weekly Conference

  4. Otolaryngology Resident and Student Weekly Case Presentations

  5. Anatomy Clinical Correlation Lecture

  6. Medical Student and Resident Research program

  7. Theme Leader for Module 1 in Biochemistry

  8. Elective Course for first & second year students: Oto/HNS Translational Research 1/2001

  9. Selective for 4th year: Inpatient Acting Internship (Course Director)

  10. Upper Airway Diseases: Module 2 Pulmonary/Respiratory Disease 2003


UNIVERSITY SERVICE

        1. Invasive CommitteeVA 1995-1997

        2. Clinic and OR Patient Care 1995-present

        3. Cancer Center Committee 1997-present

        4. Translational Research Committee 1997-1999

        5. Gene Therapy Committee 1997-1999

        6. Operative and other Invasive Procedures 1998-1999

        7. LCME Junior Faculty Committee 1998-1999

        8. Ad Hoc Committee on Tissue Procurement 1998-present

        9. Admissions Committee 1999- present

        10. Gene Therapy Advisory Board 2000-present

        11. Research Advisory Committee 2000

        12. Ad Hoc Research Investigation Board 2001

        13. Ad Hoc Search Committee for the Feist-Weiler Chair for Cancer 2001

        14. Clinical Research Committee 2001-present

        15. Dean’s Committee on Long-Range Research Planning 2001-present

        16. Research Retreat June 2002

        17. Faculty Focus Group 2002-present

        18. Core Facility of Clinical Research & training of young 2002-present

Investigators

        1. Coordinator Dept. of Otolaryngology/HNS Research Conference 2002

        2. Feist-Weiller Cancer Board 2002-present

        3. LSUHSC Foundation Support 2003

        4. Sleep Laboratory: Site Visit 2003


PUBLIC SERVICE


  1. Director of the Yul Brynner Shreveport Chapter for Screening of Head and Neck Cancer (1999-2003)

  2. Head and Neck Cancer Support Group (1997-Present)

  3. Feist-Weiller October 2002 and 2003: Hosted a luncheon table for Cancer Awareness

  4. October 19th: 3rd Annual Breast Cancer Awareness Symposium

  5. Nov. 5th: Caddo Middle Magnet School Career Day

  6. ACS Cancer Relay, 6/2/2000

  7. Breast Health Awareness Luncheon 10/16/00

  8. South Highlands School: Job Week A perspective from a Cancer Surgeon

  9. Women in Medicine Dean TV show Feb 2002

  10. Feist-Weiller Cancer Center Fund Raiser 2003, 2004


PROFESSIONAL SOCIETIES


  1. American Academy of Otolaryngology-Head and Neck Surgery

  2. American Head and Neck Society

  3. AMA

  4. Southern Medical Society

  5. Louisiana State Medical Society

  6. Southwest Oncology Group

  7. Society of University Otolaryngologists-Head and Neck Surgeons

  8. American Rhinologic Society

  9. American Association for the Advancement of Science

  10. American Association for Cancer Research
  11. American College of Surgeons

  12. Member of the Triologic Society


LICENSURES
Louisiana State Board of Medical Examiners




База данных защищена авторским правом ©shkola.of.by 2016
звярнуцца да адміністрацыі

    Галоўная старонка